#Wegovy
#Wegovy
[ follow ]
#novo-nordisk #semaglutide #glp-1 #weight-loss #ozempic #drug-pricing #oral-glp-1 #glp-1-drugs #fda-approval
fromFast Company
1 month agoWegovy pill: Where to find Novo Nordisk's new GLP-1 for weight loss-and how much it costs
The Wegovy pill-which has been in clinical trials for over two years and was approved by the FDA on December 22-is the first and only oral GLP-1 for weight loss in adults available in the U.S. According to a press release from Novo Nordisk, the pill hit the market on January 5 at more than 70,000 U.S. pharmacies and several popular telehealth providers. Per a KFF health tracking poll released in November, one in eight Americans were already taking a GLP-1 for weight-loss.
Medicine
fromwww.npr.org
1 month agoU.S. regulators approve Wegovy pill for weight loss
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration's approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly's oral drug, orforglipron, is still under review. Both pills are GLP-1 drugs that work like widely used injectables to mimic a natural hormone that controls appetite and feelings of fullness.
Medicine
Wellness
fromLondon Business News | Londonlovesbusiness.com
5 months agoPrioritising employee wellbeing: How weight management supports a productive workforce - London Business News | Londonlovesbusiness.com
Supporting employee weight management improves energy, focus, reduces health risks, lowers absenteeism, and enhances productivity and cost-efficiency.
#ozempic
Wearables
fromNew York Post
9 months agoExclusive | Grandma of 11 and NJ man join growing chorus of Ozempic, Wegovy users claiming severe vision loss
Users of weight-loss drugs Ozempic and Wegovy report severe side effects, including vision loss, prompting lawsuits against the manufacturer for failure to disclose risks.
[ Load more ]